Edwards Lifesciences (EW) Reaches $151.43 High on Jun, 13; Bsquare (BSQR)’s Sentiment Is 0.55

June 13, 2018 - By Hilary Hom

BSQUARE Corporation (NASDAQ:BSQR) Logo

Bsquare Corp (BSQR) investors sentiment decreased to 0.55 in Q1 2018. It’s down -1.45, from 2 in 2017Q4. The ratio turned negative, as 6 hedge funds opened new or increased holdings, while 11 trimmed and sold stock positions in Bsquare Corp. The hedge funds in our database now have: 4.02 million shares, down from 4.18 million shares in 2017Q4. Also, the number of hedge funds holding Bsquare Corp in top ten holdings was flat from 0 to 0 for the same number . Sold All: 5 Reduced: 6 Increased: 3 New Position: 3.

The stock of Edwards Lifesciences Corporation (NYSE:EW) reached all time high today, Jun, 13 and still has $165.06 target or 9.00% above today’s $151.43 share price. This indicates more upside for the $31.92B company. This technical setup was reported by Barchart.com. If the $165.06 PT is reached, the company will be worth $2.87B more. The stock increased 1.96% or $2.91 during the last trading session, reaching $151.43. About 475,717 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 19.08% since June 13, 2017 and is uptrending. It has outperformed by 6.51% the S&P500. Some Historical EW News: ; 10/04/2018 – Edwards Lifesciences To Host Earnings Conference Call On April 24, 2018; 21/03/2018 – Edwards Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe; 20/04/2018 – Edwards Lifesciences is simplifying heart surgery, and it’s a buy by @JimCramer’s standards; 24/04/2018 – After-hours buzz: TXN, WYNN, EW & more; 24/04/2018 – EDWARDS LIFESCIENCES – 2018 ADJ SHR OUTLOOK RAISED TO $4.50 TO $4.70 FROM $4.43 TO $4.63; 09/03/2018 MOODY’S: OUTLOOK FOR US MEDICAL PRODUCTS AND DEVICES INDUSTRY CHANGED TO POSITIVE; 01/05/2018 – Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement; 14/05/2018 – Edwards Lifesciences To Webcast Annual Meeting Of Stockholders; 24/04/2018 – EDWARDS LIFESCIENCES – REMAINS CONFIDENT IN ACHIEVING HIGHER END OF 2018 SALES OUTLOOK RANGE OF $3.5 BLN TO $3.9 BLN; 16/04/2018 – Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences

BSQUARE Corporation provides software solutions and related engineering services to businesses that develop, market, and sell standalone intelligent systems in North America, Asia, and Europe. The company has market cap of $39.98 million. The Company’s software products include HTML5 rendering engine that is based on the open-source WebKit platform and facilitates device makers to create applications and user interfaces for their devices; and TestQuest 10, a software testing automation tool. It currently has negative earnings. The firm also offers DataV software Services, such as integration with enterprise databases; integration with internal enterprise systems; integration with external public or third-party data sources; custom application development; management of customer cloud instances hosting DataV software; training; and software integration on remote devices.

Thomson Horstmann & Bryant Inc holds 0.43% of its portfolio in BSQUARE Corporation for 768,757 shares. Perritt Capital Management Inc owns 100,000 shares or 0.12% of their US portfolio. Moreover, Gsa Capital Partners Llp has 0.01% invested in the company for 60,400 shares. The North Carolina-based Bank Of America Corp De has invested 0% in the stock. Bank Of New York Mellon Corp, a New York-based fund reported 10,090 shares.

Since January 1, 0001, it had 2 buys, and 0 insider sales for $11,322 activity.

More news for BSQUARE Corporation (NASDAQ:BSQR) were recently published by: Seekingalpha.com, which released: “Bsquare Corp’s (BSQR) CEO Kevin Walsh on Q1 2018 Results – Earnings Call Transcript” on May 16, 2018. Benzinga.com‘s article titled: “41 Biggest Movers From Yesterday” and published on May 17, 2018 is yet another important article.

The stock increased 1.61% or $0.05 during the last trading session, reaching $3.15. About 53 shares traded. BSQUARE Corporation (BSQR) has declined 29.59% since June 13, 2017 and is downtrending. It has underperformed by 42.16% the S&P500. Some Historical BSQR News: ; 18/05/2018 – PALOGIC VALUE MANAGEMENT SAYS HAVE & MAY IN FUTURE, ENGAGE IN DISCUSSIONS WITH BSQUARE’S BOARD ABOUT POTENTIAL TRANSACTIONS, AMONG OTHER ISSUES; 18/05/2018 – PALOGIC VALUE HAS HAD, MAY CONTINUE TALKS WITH BSQUARE; 15/05/2018 – Bsquare Secures Three-Yr IoT SaaS Agreement With Fortune 100 Firm Covering Tens of Thousands of Connected Devices; 18/05/2018 – PALOGIC VALUE MANAGEMENT REPORTS 7 PCT STAKE IN BSQUARE CORP AS ON MAY 18 – SEC FILING; 15/05/2018 – BSQUARE 1Q Loss/Shr 19c; 15/05/2018 – Bsquare Secures Three-Year IoT SaaS Agreement with Fortune 100 Firm Covering Tens of Thousands of Connected Devices; 15/05/2018 – BSQUARE Sees 2Q Rev $16M-$18M; 09/05/2018 – Bsquare Announces New Leadership, CEO Steps Down; 09/05/2018 – BSQUARE CORP – KEVIN WALSH APPOINTED TO SERVE AS ACTING CEO; 15/03/2018 Bsquare to Attend the Sidoti & Company Spring 2018 Investor Conference on March 29

Among 29 analysts covering Edwards Lifesciences Corp (NYSE:EW), 22 have Buy rating, 1 Sell and 6 Hold. Therefore 76% are positive. Edwards Lifesciences Corp had 113 analyst reports since July 30, 2015 according to SRatingsIntel. BMO Capital Markets maintained it with “Buy” rating and $132.0 target in Thursday, August 31 report. Northland Capital upgraded the shares of EW in report on Tuesday, November 8 to “Outperform” rating. The firm has “Buy” rating by Cowen & Co given on Friday, December 8. The rating was downgraded by BTIG Research to “Neutral” on Thursday, February 2. The company was maintained on Wednesday, July 27 by Barclays Capital. BTIG Research maintained Edwards Lifesciences Corporation (NYSE:EW) on Wednesday, July 27 with “Buy” rating. Stifel Nicolaus maintained the stock with “Buy” rating in Wednesday, April 26 report. The stock of Edwards Lifesciences Corporation (NYSE:EW) has “Mkt Perform” rating given on Wednesday, January 6 by JMP Securities. The rating was downgraded by Northland Capital on Wednesday, April 25 to “Hold”. Bank of America upgraded the shares of EW in report on Thursday, July 27 to “Buy” rating.

BSQUARE Corporation (NASDAQ:BSQR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: